Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 4/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.47 |
| ▸ | CASP2 | P42575 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | NAAA | Q02083 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.43 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4813304 | 1.00 | FAAH (0.49) | FAAHSMN1; SMN2HPGDHTTDNM1 | |
| SCHEMBL6048378 | 1.00 | FAAH (0.49) | FAAHSMN1; SMN2HPGDHTTDNM1 | |
| SCHEMBL6048382 | 1.00 | FAAH (0.49) | FAAHSMN1; SMN2HPGDHTTDNM1 | |
| SCHEMBL25542920 | 0.97 | CASP2 (0.50) | FAAHSMN1; SMN2HPGDHTTDNM1 | |
| SCHEMBL18972339 | 0.95 | L3MBTL1 (0.52) | FAAHSMN1; SMN2HPGDHTTDNM1 | |
| SCHEMBL10140378 | 0.95 | L3MBTL1 (0.52) | FAAHSMN1; SMN2HPGDHTTDNM1 | |
| SCHEMBL19647019 | 0.95 | SMN1; SMN2 (0.48) | FAAHSMN1; SMN2HPGDHTTDNM1 | |
| SCHEMBL11990467 | 0.93 | L3MBTL1 (0.50) | FAAHSMN1; SMN2HPGDHTTDNM1 | |
| SCHEMBL4818636 | 0.93 | SMN1; SMN2 (0.49) | FAAHSMN1; SMN2HPGDHTTDNM1 | |
| SCHEMBL337575 | 0.93 | SMN1; SMN2 (0.49) | FAAHSMN1; SMN2HPGDHTTDNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060199763-A1 | Derivatives of GLP-1 analogs | KNUDSEN LISELOTTE B | 2006-09-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060199763-A1 | Derivatives of GLP-1 analogs | GLP1R, GIPR, IAPP | FAAH 587/4885SMN1; SMN2 1991/4885HPGD 3166/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.